Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey.
BACKGROUND: Investigation of genetic heterogeneity and spoligotype-defined lineages of drug-resistant Mycobacterium tuberculosis clinical isolates collected during a three-year period in two university hospitals and National Tuberculosis Reference and Research Laboratory in Ankara, Turkey. METHODS A...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3261197?pdf=render |
| _version_ | 1818277465635684352 |
|---|---|
| author | Ozgul Kisa Gulnur Tarhan Selami Gunal Ali Albay Riza Durmaz Zeynep Saribas Thierry Zozio Alpaslan Alp Ismail Ceyhan Ahmet Tombak Nalin Rastogi |
| author_facet | Ozgul Kisa Gulnur Tarhan Selami Gunal Ali Albay Riza Durmaz Zeynep Saribas Thierry Zozio Alpaslan Alp Ismail Ceyhan Ahmet Tombak Nalin Rastogi |
| author_sort | Ozgul Kisa |
| collection | DOAJ |
| description | BACKGROUND: Investigation of genetic heterogeneity and spoligotype-defined lineages of drug-resistant Mycobacterium tuberculosis clinical isolates collected during a three-year period in two university hospitals and National Tuberculosis Reference and Research Laboratory in Ankara, Turkey. METHODS AND FINDINGS: A total of 95 drug-resistant M. tuberculosis isolates collected from three different centers were included in this study. Susceptibility testing of the isolates to four major antituberculous drugs was performed using proportion method on Löwenstein-Jensen medium and BACTEC 460-TB system. All clinical isolates were typed by using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) methods. Seventy-three of the 95 (76.8%) drug resistant M. tuberculosis isolates were isoniazid-resistant, 45 (47.4%) were rifampicin-resistant, 32 (33.7%) were streptomycin-resistant and 31 (32.6%) were ethambutol-resistant. The proportion of multidrug-resistant isolates (MDR) was 42.1%. By using spoligotyping, 35 distinct patterns were observed; 75 clinical isolates were grouped in 15 clusters (clustering rate of 79%) and 20 isolates displayed unique patterns. Five of these 20 unique patterns corresponded to orphan patterns in the SITVIT2 database, while 4 shared types containing 8 isolates were newly created. The most prevalent M. tuberculosis lineages were: Haarlem (23/95, 24.2%), ill-defined T superfamily (22/95, 23.2%), the Turkey family (19/95, 20%; previously designated as LAM7-TUR), Beijing (6/95, 6.3%), and Latin-America & Mediterranean (LAM, 5/95 or 5.3%), followed by Manu (3/95, 3.2%) and S (1/95, 1%) lineages. Four of the six Beijing family isolates (66.7%) were MDR. A combination of IS6110-RFLP and spoligotyping reduced the clustering rate from 79% to 11.5% among the drug resistant isolates. CONCLUSIONS: The results obtained showed that ill-defined T, Haarlem, the Turkey family (previously designated as LAM7-TUR family with high phylogeographical specifity for Turkey), Beijing and LAM were predominant lineages observed in almost 80% of the drug-Resistant M. tuberculosis complex clinical isolates in Ankara, Turkey. |
| first_indexed | 2024-12-12T23:01:59Z |
| format | Article |
| id | doaj.art-d8ad8ff1f1b240fd8a7c972782ebba89 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-12T23:01:59Z |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-d8ad8ff1f1b240fd8a7c972782ebba892022-12-22T00:08:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0171e3033110.1371/journal.pone.0030331Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey.Ozgul KisaGulnur TarhanSelami GunalAli AlbayRiza DurmazZeynep SaribasThierry ZozioAlpaslan AlpIsmail CeyhanAhmet TombakNalin RastogiBACKGROUND: Investigation of genetic heterogeneity and spoligotype-defined lineages of drug-resistant Mycobacterium tuberculosis clinical isolates collected during a three-year period in two university hospitals and National Tuberculosis Reference and Research Laboratory in Ankara, Turkey. METHODS AND FINDINGS: A total of 95 drug-resistant M. tuberculosis isolates collected from three different centers were included in this study. Susceptibility testing of the isolates to four major antituberculous drugs was performed using proportion method on Löwenstein-Jensen medium and BACTEC 460-TB system. All clinical isolates were typed by using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) methods. Seventy-three of the 95 (76.8%) drug resistant M. tuberculosis isolates were isoniazid-resistant, 45 (47.4%) were rifampicin-resistant, 32 (33.7%) were streptomycin-resistant and 31 (32.6%) were ethambutol-resistant. The proportion of multidrug-resistant isolates (MDR) was 42.1%. By using spoligotyping, 35 distinct patterns were observed; 75 clinical isolates were grouped in 15 clusters (clustering rate of 79%) and 20 isolates displayed unique patterns. Five of these 20 unique patterns corresponded to orphan patterns in the SITVIT2 database, while 4 shared types containing 8 isolates were newly created. The most prevalent M. tuberculosis lineages were: Haarlem (23/95, 24.2%), ill-defined T superfamily (22/95, 23.2%), the Turkey family (19/95, 20%; previously designated as LAM7-TUR), Beijing (6/95, 6.3%), and Latin-America & Mediterranean (LAM, 5/95 or 5.3%), followed by Manu (3/95, 3.2%) and S (1/95, 1%) lineages. Four of the six Beijing family isolates (66.7%) were MDR. A combination of IS6110-RFLP and spoligotyping reduced the clustering rate from 79% to 11.5% among the drug resistant isolates. CONCLUSIONS: The results obtained showed that ill-defined T, Haarlem, the Turkey family (previously designated as LAM7-TUR family with high phylogeographical specifity for Turkey), Beijing and LAM were predominant lineages observed in almost 80% of the drug-Resistant M. tuberculosis complex clinical isolates in Ankara, Turkey.http://europepmc.org/articles/PMC3261197?pdf=render |
| spellingShingle | Ozgul Kisa Gulnur Tarhan Selami Gunal Ali Albay Riza Durmaz Zeynep Saribas Thierry Zozio Alpaslan Alp Ismail Ceyhan Ahmet Tombak Nalin Rastogi Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey. PLoS ONE |
| title | Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey. |
| title_full | Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey. |
| title_fullStr | Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey. |
| title_full_unstemmed | Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey. |
| title_short | Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey. |
| title_sort | distribution of spoligotyping defined genotypic lineages among drug resistant mycobacterium tuberculosis complex clinical isolates in ankara turkey |
| url | http://europepmc.org/articles/PMC3261197?pdf=render |
| work_keys_str_mv | AT ozgulkisa distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT gulnurtarhan distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT selamigunal distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT alialbay distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT rizadurmaz distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT zeynepsaribas distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT thierryzozio distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT alpaslanalp distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT ismailceyhan distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT ahmettombak distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey AT nalinrastogi distributionofspoligotypingdefinedgenotypiclineagesamongdrugresistantmycobacteriumtuberculosiscomplexclinicalisolatesinankaraturkey |